Clinical Trial Update: A Study to Assess the Efficacy and Safety of Two Dosing Regimens of Alefacept in Subjects Weighing Between 100kg and 150kg With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating two dosing regimens of alefacept in adults with moderate to severe chronic plaque psoriasis has completed. The sponsor is Astellas Phar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Amevive (alefacept)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Chronic Plaque Psoriasis | Phase 3 | Status: COMPLETED